Thyroid Cancer Clinical Trials - Mayo Clinic Research
WebThe purpose of this study is to explore how using different terms (with or without the word cancer) to identify papillary thyroid cancer might affect the decisions patients would make about treatment.
Advances in Thyroid Cancer Research - NCI
WebIn rare cases, papillary or follicular thyroid cancer can be aggressive and grow and spread despite surgery and radioactive iodine treatment. The Food and Drug Administration (FDA) has approved two targeted drugs for such cancers: sorafenib tosylate (Nexavar) and lenvatinib (Lenvima).
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer ...
WebFeb 12, 2015 · In our phase 3, randomized, double-blind, multicenter study involving patients with progressive thyroid cancer that was refractory to iodine-131, we randomly assigned 261 patients to receive...
Clinical Trials & Research for Thyroid Cancer | Memorial Sloan ...
WebAmong other discoveries, we: characterized the “genetic fingerprint” to predict responsiveness to radioactive iodine therapy for papillary thyroid cancer, and the likelihood of disease spread. identified hurthle cell carcinoma as …
Immunotherapy for advanced thyroid cancers - Nature
WebAug 24, 2020 · Physiologically relevant preclinical mouse models and human correlative research studies will inform development of the next stage of immune-based therapies for patients with advanced thyroid...
Expanded Parameters in Active Surveillance for Low-risk Papillary ...
WebAn observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34 (1):28-35. doi: 10.1007/s00268-009-0303-0 PubMed Google Scholar Crossref. Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto Y.
Select thyroid clinical trials at Mayo Clinic - Mayo Clinic
WebMayo Clinic researchers are investigating therapeutic use of radiofrequency ablation for small papillary thyroid carcinomas. A placebo-controlled interventional trial is testing a new therapy for patients with thyroid eye disease.
Thyroid Cancer Treatment (PDQ®) - NCI
WebApr 11, 2024 · Clinical trials evaluating new treatment approaches to this disease should be considered for patients with radioiodine-refractory papillary or follicular thyroid cancer. Oral inhibitors targeting specific activating point mutations are under clinical evaluation, as are new immunotherapy approaches.[ 27 - 29 ][ Level of evidence B4 ]
A Study to Evaluate Treatment of Papillary Thyroid Carcinoma …
WebThe purpose of this study is to evaluate the efficiency of Radiofrequency ablation (RFA) therapy to treat papillary thyroid carcinoma. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and …
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary …
WebOct 17, 2023 · Papillary thyroid carcinoma (PTC) is the most common thyroid cancer and has a good prognosis.According to the 2015 American thyroid association (ATA) guidelines, no gross extrathyroidal extension and the number of pathological lymph node micrometastases (<0.2cm) ≤5 were defined as the low recurrence risk group.
Skip to content